Challenges of equitable access to device-aided therapies for advanced Parkinson's Disease in Poland - expert consensus and treatment recommendations.

IF 2.9 4区 医学 Q2 CLINICAL NEUROLOGY Neurologia i neurochirurgia polska Pub Date : 2024-01-01 DOI:10.5603/pjnns.102680
Karolina Popławska-Domaszewicz, Joanna Siuda, Monika Rudzińska-Bar, Slawomir Budrewicz, Dariusz Koziorowski, Andrzej Bogucki, K Ray Chaudhuri, Jarosław Sławek
{"title":"Challenges of equitable access to device-aided therapies for advanced Parkinson's Disease in Poland - expert consensus and treatment recommendations.","authors":"Karolina Popławska-Domaszewicz, Joanna Siuda, Monika Rudzińska-Bar, Slawomir Budrewicz, Dariusz Koziorowski, Andrzej Bogucki, K Ray Chaudhuri, Jarosław Sławek","doi":"10.5603/pjnns.102680","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>In Poland, not all forms of device-aided therapies for advanced Parkinson's Disease (APD) are currently available.</p><p><strong>Material and methods: </strong>We aimed to produce a consensus recommendation from Polish movement disorders experts after discussing gaps in the APD care pathway in Poland.</p><p><strong>Results: </strong>Rescue therapy with apomorphine (APO) PEN injection and levodopa-entacapone-carbidopa intestinal gel infusion are not included in Poland's Specialist Therapeutic Programme, and are thus not reimbursed. For APO infusion, only the medication is reimbursed but not the device.</p><p><strong>Conclusions: </strong>Consensus expert opinion is that APD patients in Poland would benefit from additional reimbursement access to these treatment options to improve APD patient care.</p>","PeriodicalId":19132,"journal":{"name":"Neurologia i neurochirurgia polska","volume":"58 6","pages":"608-616"},"PeriodicalIF":2.9000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurologia i neurochirurgia polska","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5603/pjnns.102680","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: In Poland, not all forms of device-aided therapies for advanced Parkinson's Disease (APD) are currently available.

Material and methods: We aimed to produce a consensus recommendation from Polish movement disorders experts after discussing gaps in the APD care pathway in Poland.

Results: Rescue therapy with apomorphine (APO) PEN injection and levodopa-entacapone-carbidopa intestinal gel infusion are not included in Poland's Specialist Therapeutic Programme, and are thus not reimbursed. For APO infusion, only the medication is reimbursed but not the device.

Conclusions: Consensus expert opinion is that APD patients in Poland would benefit from additional reimbursement access to these treatment options to improve APD patient care.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
波兰晚期帕金森病器械辅助治疗公平获取的挑战——专家共识和治疗建议
在波兰,并不是所有形式的设备辅助治疗晚期帕金森病(APD)目前可用。材料和方法:我们的目标是在讨论波兰APD护理途径的差距后,产生波兰运动障碍专家的共识建议。结果:阿波啡(APO) PEN注射剂和左旋多巴-恩他卡彭-卡比多巴肠道凝胶输注的抢救治疗不包括在波兰的专科治疗方案中,因此不报销。对于APO输注,只报销药物而不报销设备。结论:专家一致认为,波兰的APD患者将受益于这些治疗方案的额外报销,以改善APD患者的护理。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Neurologia i neurochirurgia polska
Neurologia i neurochirurgia polska 医学-临床神经学
CiteScore
4.20
自引率
27.60%
发文量
128
审稿时长
6-12 weeks
期刊介绍: Polish Journal of Neurology and Neurosurgery is an official journal of the Polish Society of Neurology and the Polish Society of Neurosurgeons, aimed at publishing high quality articles within the field of clinical neurology and neurosurgery, as well as related subspecialties. For more than a century, the journal has been providing its authors and readers with the opportunity to report, discuss, and share the issues important for every-day practice and research advances in the fields related to neurology and neurosurgery.
期刊最新文献
John Cunningham virus as cause of progressive multifocal leukoencephalopathy. Neurotoxicity of levodopa/carbidopa intestinal gel preparations can cause polyneuropathy in Parkinson's Disease patients. Response to: DNAJC30 variants can also manifest phenotypically as Leigh/LHON overlap syndrome. From rarity to reality: Poland's first case of neurological Erdheim-Chester Disease with cerebellar manifestations. Recommendations of Multiple Sclerosis and Neuroimmunology Section of Polish Neurological Society and Immuno-oncology Section of Polish Society of Oncology on oncological risk in patients with multiple sclerosis undergoing immunomodulatory therapy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1